Holen Sie sich die Stockscreener-App
0.232
6.18%
0.0135
Handel nachbörslich:
.19
-0.042
-18.10%
Schlusskurs vom Vortag:
$0.2185
Offen:
$0.229
24-Stunden-Volumen:
4.75M
Relative Volume:
1.46
Marktkapitalisierung:
$5.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.41%
1M Leistung:
-1.61%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.2232
$0.2713
1-Wochen-Bereich:
$0.2174
$0.2826
52-Wochen-Spanne:
$0.1607
$1.09
Ping An Biomedical Co Ltd Stock (PASW) Company Profile
Firmenname
Ping An Biomedical Co Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare PASW vs AIN, UFI, CULP
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASW
Ping An Biomedical Co Ltd
|
0.232 | 5.36M | 0 | 0 | 0 | 0.00 |
|
AIN
Albany International Corp
|
57.88 | 1.64B | 1.27B | 100.39M | 116.84M | 3.20 |
|
UFI
Unifi Inc
|
4.01 | 76.18M | 583.56M | -53.59M | -18.48M | -2.97 |
|
CULP
Culp Inc
|
3.58 | 44.57M | 237.23M | -13.64M | -6.50M | -1.10 |
Ping An Biomedical Co Ltd Aktie (PASW) Neueste Nachrichten
13F report shows: Ontario Teachers’ Pension Plan (OTPP) established long positions in Meta and others in Q4 - Bitget
13F report shows: Barclays increased holdings in Micron Technology, Google C, Gilead Sciences, Applied Materials, and Kenvue in Q4 - Bitget
13F report shows: Carlyle Group established long positions in Medline, popular broker Robinhood, and Spyre Therapeutics in Q4 - Bitget
According to the latest documents disclosed by the US SEC, up to 13.6 million ordinary shares of Ping An Biomedical Co., Ltd. will be resold by its selling shareholders. - Bitget
Ping An Biomedical Raises $4 Million in Private Share Placement - TipRanks
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session - Benzinga
NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization - digitalmore.co
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session - Benzinga
FLYEXCLUSIVE INC. (FLYX) Stock, Price, News, Quotes, Forecast and Insights - MSN
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session - Benzinga
11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Morgan Stanley Lowers Price Target on JD.com to $24 From $28, Keeps Underweight Rating - marketscreener.com
These stocks that are showing activity before the opening bell on Tuesday. - Chartmill
Why Heritage Global Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday? - Chartmill
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session - Benzinga
Trading Activity Highlights: Nasdaq & NYSE Leaders on January 12, 2026News and Statistics - IndexBox
Ping An Biomedical Secures Strategic Investment from Leading Chinese Tech and VC Executives to Accelerate Biopharma Growth - TipRanks
Ping An Biomedical Shares Surge After Securing Strategic Investment - Nasdaq
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Crypto: PASW Warning: Key Support Level Being Tested Right Now - InteractiveCrypto
United States shares higher at close of trade; Dow Jones Industrial Average up 0.48% By Investing.com - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com
Future Biotechnology Group Co., Ltd announced that it expects to receive $90 million in funding from Ping An Biomedical Co., Ltd. - marketscreener.com
Ping An Biomedical Co., Ltd. announced a financing transaction - MarketScreener
Ping An Biomedical (PASW) Stock: Gains Strategic Investors While Addressing Nasdaq Compliance - parameter.io
11 Consumer Discretionary Stocks Moving In Friday's Intraday Session - Benzinga
Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com - Investing.com Australia
Remedy’s Nutrition® Unveils Hair Tissue Mineral Analysis: A Revolutionary Personalized Approach to Nutritional Wellness - The Manila Times
Ping An Bio to invest $90 million in Future Biotechnology Group By Investing.com - Investing.com South Africa
Shopley Announces Steve Levely as Chief Executive Officer - The Manila Times
Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results - The Manila Times
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - The Manila Times
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry - The Manila Times
Sienna Announces Fourth Quarter 2025 Results Release Date and Conference Call - The Manila Times
Greenstone Files Early Warning Report for Marimaca Copper Corp. - The Manila Times
ACTG Launches IPACE-HIV to Study Frailty Intervention - The Manila Times
ProMach Acquires American Holt, DMA Solution, and Pride Engineering from Arcline - The Manila Times
Ping An Biomedical secures investment from three notable investors By Investing.com - Investing.com Nigeria
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026 - The Manila Times
uniQure Announces Type A Meeting Scheduled with FDA - The Manila Times
La Rosa Holdings Corp. Announces Closing of Initial Funding Under $250 Million Note Facility as Part of $1.25 Billion AI Infrastructure Program - The Manila Times
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation - The Manila Times
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference - The Manila Times
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker 'LONA” - The Manila Times
Finanzdaten der Ping An Biomedical Co Ltd-Aktie (PASW)
Es liegen keine Finanzdaten für Ping An Biomedical Co Ltd (PASW) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.70%
2.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):